Form 4: Credit Acceptance Corp Executive Daniel Ulatowski Sells Shares
SEC Form 4 Filing
Daniel Ulatowski, Chief Sales Officer of Credit Acceptance Corp, sold shares held in trust at prices ranging from $470.77 to $480 on August 7, 2024.
Summary
- On August 7, 2024, Daniel A. Ulatowski, Chief Sales Officer of Credit Acceptance Corp, sold shares of common stock held in the D.&.B. Ulatowski Living Trust.
- The sales occurred in multiple transactions with prices ranging from $470.77 to $480 per share.
- A total of 1,995 shares were sold from the trust.
- Following the reported transactions, the trust holds 4,000 shares.
- Ulatowski also indirectly owns 53 shares through a 401(k) Trust.
- Ulatowski directly owns an employee stock option representing the right to buy 50,000 shares of common stock at an exercise price of $333.94, which is exercisable in annual installments that began on December 30, 2021.
Sentiment
Score: 5
Explanation: Neutral sentiment. The document simply reports stock sales by an executive, which could be for a variety of personal financial reasons and doesn't necessarily reflect a negative outlook on the company.
Negatives
- The sale of shares by a company executive could be interpreted negatively by the market.
Risks
- Executive stock sales can sometimes signal a lack of confidence in the company's future performance, although this is not always the case.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Investors often monitor these filings for signals about executive sentiment regarding the company's prospects.
Comparison to Industry Standards
- Executive compensation packages, including stock options, are common in the financial services industry.
- Comparing Ulatowski's stock option grants and sales to those of executives at similar companies like Ally Financial or Capital One could provide context on whether these transactions are typical.
Stakeholder Impact
- Shareholders may react to the news of executive stock sales, potentially impacting the stock price in the short term.
- The impact on other stakeholders (employees, customers, suppliers, creditors) is likely to be minimal unless the sales are indicative of a larger issue within the company.
Key Dates
| Date | Description |
|---|---|
| 12/30/2021 | First anniversary of the date on which the employee stock option was granted, and the date when the option became exercisable in four equal annual installments. |
| 08/07/2024 | Date of the reported stock sales. |
| 08/09/2024 | Date of signature on the Form 4 filing. |
| 12/30/2026 | Expiration date of the employee stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.